 "14 stocks that rallied over 50% each in last three Samvat years")
Bajaj Finance, Dwarikesh Sugar Industries, V2 Retail, Motilal Oswal Financial Services and Caplin Point Laboratories are among 14 stocks from the BSE Smallcap and BSE500 index that rallied an over 50% each in last three Samvat years between 2071 and 2073.
Emmbi Industries, Medicamen Biotec, Garware-Wall Ropes, Thirumalai Chemicals, IG Petrochemicals, Bajaj Finserv, APL Apollo Tubes, Agarwal Industrial Corporation and Heritage Foods too gained an over 50% in past three Samvat years.
Dwarikesh Sugar Industries and Medicamen Biotec have doubled or more in past three years. V2 Retail, IG Petrochemicals and Thirumalai Chemicals have gained over 100% in two out of three Samvat years.
These 14 stocks surged in the range of 380% to 4330% between the Samvat years 2071 and 2073. The S&P BSE Smallcap index have rallied 26% thus far in Samvat year 2073, gained 5% and 21% in Samvat year 2071 and 2072, respectively.
Medicamen Biotec jumped an enormous 4327%, from Rs 13.50 on October 23, 2014 to Rs 597.60 on October 17, 2017.
Emmbi Industries, Medicamen Biotec, Garware-Wall Ropes, Thirumalai Chemicals, IG Petrochemicals, Bajaj Finserv, APL Apollo Tubes, Agarwal Industrial Corporation and Heritage Foods too gained an over 50% in past three Samvat years.
Dwarikesh Sugar Industries and Medicamen Biotec have doubled or more in past three years. V2 Retail, IG Petrochemicals and Thirumalai Chemicals have gained over 100% in two out of three Samvat years.
These 14 stocks surged in the range of 380% to 4330% between the Samvat years 2071 and 2073. The S&P BSE Smallcap index have rallied 26% thus far in Samvat year 2073, gained 5% and 21% in Samvat year 2071 and 2072, respectively.
Medicamen Biotec jumped an enormous 4327%, from Rs 13.50 on October 23, 2014 to Rs 597.60 on October 17, 2017.
Incorporated in 1993, headquartered in New Delhi, Medicamen Biotech is engaged in the manufacturing and marketing of pharmaceutical formulations across overseas and domestic market. Major part of sales volume is generated through the Rest of World (ROW) countries.
“After taken over by the new promoters, the new team dedicatedly worked in the financial year 2016-17 (FY17) and able to achieve the turnover of company of Rs 82.46 crore and managed to earn a profit of Rs 5.16 crore. It reported turnover of Rs 67.27 crore and profit of Rs 48 lakh in FY16,” Medicamen Biotec said in FY17 annual report.
V2 Retail, IG Petrochemicals and Thirumalai Chemicals have recorded more than 100% returns in past two consecutive Samvat years.
V2 Retail hit a fresh 52-week high of Rs 549 on the BSE in intra-day trade today. The stock zoomed 1688% or 18-fold from its level of Rs 30.70 on October 23, 2014.
V2 Retail is one of the fastest growing retail companies in India and enjoys strong brand equity from customers across segments. The Company offers a portfolio of products, including apparel and life style products.
The company on Monday, October 16, 2017 said that the funds affiliated with private equity (PE) firm Lighthouse made an investment of Rs 76 crore in the company. The investment will be used to accelerate V2 Retail’s store expansion plans.
The board of directors of V2 Retail approved allotment of two million equity shares to India 2020 Fund II (foreign portfolio investor), non-promoter, at a price of Rs 380 per share.
For FY17, V2 Retail achieved revenue of approximately Rs 470 crore, representing a CAGR (compound annual growth rate) in excess of 60% over the last five years. Currently, the Company has 44 stores across 13 states in India and targets reaching a store count of 100 in the next two to three years, it added.
“After taken over by the new promoters, the new team dedicatedly worked in the financial year 2016-17 (FY17) and able to achieve the turnover of company of Rs 82.46 crore and managed to earn a profit of Rs 5.16 crore. It reported turnover of Rs 67.27 crore and profit of Rs 48 lakh in FY16,” Medicamen Biotec said in FY17 annual report.
V2 Retail, IG Petrochemicals and Thirumalai Chemicals have recorded more than 100% returns in past two consecutive Samvat years.
V2 Retail hit a fresh 52-week high of Rs 549 on the BSE in intra-day trade today. The stock zoomed 1688% or 18-fold from its level of Rs 30.70 on October 23, 2014.
V2 Retail is one of the fastest growing retail companies in India and enjoys strong brand equity from customers across segments. The Company offers a portfolio of products, including apparel and life style products.
The company on Monday, October 16, 2017 said that the funds affiliated with private equity (PE) firm Lighthouse made an investment of Rs 76 crore in the company. The investment will be used to accelerate V2 Retail’s store expansion plans.
The board of directors of V2 Retail approved allotment of two million equity shares to India 2020 Fund II (foreign portfolio investor), non-promoter, at a price of Rs 380 per share.
For FY17, V2 Retail achieved revenue of approximately Rs 470 crore, representing a CAGR (compound annual growth rate) in excess of 60% over the last five years. Currently, the Company has 44 stores across 13 states in India and targets reaching a store count of 100 in the next two to three years, it added.
| Price on BSE in Rs | Returns in %* | ||||||
| COMPANY | 23/10/2014 | 11/11/2015 | 30/10/2016 | 17/10/2017 | 2071 | 2072 | 2073 |
| Emmbi Industries | 15.27 | 68.10 | 135.35 | 224.10 | 346.0 | 98.8 | 65.6 |
| Caplin Point Lab | 85.83 | 261.85 | 397.40 | 695.35 | 205.1 | 51.8 | 75.0 |
| Medicamen Biotec | 13.50 | 36.05 | 282.40 | 597.60 | 167.0 | 683.4 | 111.6 |
| Dwarikesh Sugar | 3.15 | 7.41 | 26.51 | 73.85 | 135.2 | 257.8 | 178.6 |
| Garware-Wall Ropes | 159.50 | 355.60 | 555.35 | 898.70 | 122.9 | 56.2 | 61.8 |
| V2 Retail | 30.70 | 60.50 | 140.70 | 525.65 | 97.1 | 132.6 | 273.6 |
| Bajaj Finance | 272.91 | 537.38 | 1080.60 | 1867.05 | 96.9 | 101.1 | 72.8 |
| I G Petrochems | 59.55 | 112.40 | 303.55 | 756.15 | 88.7 | 170.1 | 149.1 |
| Bajaj Finserv | 1040.25 | 1946.55 | 3408.15 | 5356.50 | 87.1 | 75.1 | 57.2 |
| Thirumalai Chemicals | 102.05 | 187.30 | 920.70 | 1851.35 | 83.5 | 391.6 | 101.1 |
| APL Apollo | 319.40 | 545.50 | 891.40 | 1915.65 | 70.8 | 63.4 | 114.9 |
| Agarwal Indl. | 90.60 | 146.30 | 311.20 | 529.90 | 61.5 | 112.7 | 70.3 |
| Motilal Oswal Financial | 214.25 | 343.70 | 590.60 | 1479.40 | 60.4 | 71.8 | 150.5 |
| Heritage Foods | 163.35 | 245.55 | 455.78 | 783.50 | 50.3 | 85.6 | 71.9 |
| INDICES | |||||||
| S&P BSE Sensex | 26851 | 25867 | 27930 | 32609 | -3.7 | 8.0 | 16.8 |
| S&P BSE 500 | 10255 | 10418 | 11879 | 14247 | 1.6 | 14.0 | 19.9 |
| S&P BSE Smallcap | 10663 | 11211 | 13583 | 17066 | 5.1 | 21.2 | 25.6 |
| * % returns in Samvat year; Data Source: CapitaLine | |||||||
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%